|
Clinical trials Randomized controlled (CONSORT agreement)
Citations 201-210 of 248 total displayed.
|
Past content
(since Mar 2001):
|
- ARTICLES
A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy
- F.G. Gilliam, F. Veloso, M.A.M. Bomhof, S.K. Gazda, V. Biton, J.P. Ter Bruggen, W. Neto, C. Bailey, G. Pledger, and S.-C. Wu
Neurology 2003; 60: 196-202.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Acute migraine treatment with droperidol: A randomized, double-blind, placebo-controlled trial
- S.D. Silberstein, W.B. Young, J.E. Mendizabal, J.F. Rothrock, and A.S. Alam
Neurology 2003; 60: 315-321.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Interferon ß-1a in primary progressive MS: An exploratory, randomized, controlled trial
- S.M. Leary, D.H. Miller, V.L. Stevenson, P.A. Brex, D.T. Chard, and A.J. Thompson
Neurology 2003; 60: 44-51.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD
- J.G. Nutt, K.J. Burchiel, C.L. Comella, J. Jankovic, A.E. Lang, E.R. Laws, Jr., A.M. Lozano, R.D. Penn, R.K. Simpson, Jr., M. Stacy, and G.F. Wooten
Neurology 2003; 60: 69-73.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy
- J. R. MacDonald, J. D. Hill, and M. A. Tarnopolsky
Neurology 2002; 59: 1876-1880.
[Abstract]
[Full text]
[PDF]
- ARTICLES
A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic pain
- M. S. Wallace, M. C. Rowbotham, N. P. Katz, R. H. Dworkin, R. M. Dotson, B. S. Galer, R. L. Rauck, M. M. Backonja, S. N. Quessy, and P. D. Meisner
Neurology 2002; 59: 1694-1700.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Repetitive transcranial magnetic stimulation for Tourette syndrome
- A. Münchau, B.R. Bloem, K.V. Thilo, M.R. Trimble, J.C. Rothwell, and M.M. Robertson
Neurology 2002; 59: 1789-1791.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Randomized, comparative study of interferon ß-1a treatment regimens in MS: The EVIDENCE Trial
- H. Panitch, D.S. Goodin, G. Francis, P. Chang, P.K. Coyle, P. O’Connor, E. Monaghan, D. Li, and B. Weinshenker
Neurology 2002; 59: 1496-1506.
[Abstract]
[Full text]
[PDF]
- ARTICLES
A randomized, double-blind, dose-comparison study of weekly interferon ß-1a in relapsing MS
- M. Clanet, E.W. Radue, L. Kappos, H.P. Hartung, R. Hohlfeld, M. Sandberg-Wollheim, M.F. Kooijmans-Coutinho, E.C. Tsao, and A.W. Sandrock
Neurology 2002; 59: 1507-1517.
[Abstract]
[Full text]
[PDF]
- ARTICLES
A randomized clinical trial of CPI-1189 for HIV-associated cognitive–motor impairment
- D. B. Clifford, J. C. McArthur, G. Schifitto, K. Kieburtz, M. P. McDermott, S. Letendre, B. A. Cohen, K. Marder, R. J. Ellis, and C. M. Marra
Neurology 2002; 59: 1568-1573.
[Abstract]
[Full text]
[PDF]
|
|
